Director Sun Kang sells 1.5M Amprius (AMPX) shares in 10b5-1 plan
Rhea-AI Filing Summary
Amprius Technologies director Sun Kang exercised stock options and sold shares in a pre-planned trade. On April 1, 2026, he exercised options for a total of 1,500,000 shares of common stock at strike prices of $1.78 and $3.68 per share, then sold 1,500,000 shares in open-market transactions at average prices of $15.7328 and $16.7829, with actual sale prices ranging from $15.37 to $17.31.
Following these transactions, he holds 1,342,400 shares directly and 56,406 shares indirectly through the KANG & CECILLIA SUN FAMILY REVOCABLE TRUST. His holdings also include 1,159,385 restricted stock units, each representing a contingent right to one share. All reported trades were executed under a Rule 10b5-1 trading plan adopted on August 18, 2025, indicating they were pre-scheduled rather than discretionary.
Positive
- None.
Negative
- None.
Insights
Pre-planned option exercise and sale; net position remains sizable.
The filing shows Sun Kang exercising options for 1,500,000 shares at strike prices of $1.78 and $3.68, then selling 1,500,000 shares at average prices around $15.73 and $16.78. This is a classic exercise-and-sell pattern, converting option value into cash.
Importantly, the transactions were executed under a Rule 10b5-1 trading plan adopted on August 18, 2025, which means the timing was pre-arranged and not a reaction to recent information. After these trades, Kang still holds 1,342,400 shares directly, plus 56,406 indirectly through a family trust and 1,159,385 restricted stock units, so he maintains substantial exposure to Amprius Technologies.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option (right to buy) | 1,312,505 | $1.78 | $2.34M |
| Exercise | Stock Option (right to buy) | 187,495 | $3.68 | $690K |
| Exercise | Common stock | 1,312,505 | $1.78 | $2.34M |
| Exercise | Common stock | 187,495 | $3.68 | $690K |
| Sale | Common stock | 1,250,963 | $15.7328 | $19.68M |
| Sale | Common stock | 249,037 | $16.7829 | $4.18M |
| holding | Common stock | -- | -- | -- |
Footnotes (1)
- The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 18, 2025. Includes 1,159,385 restricted stock units, each of which represents a contingent right to receive one share of the issuer's common stock, subject to the applicable vesting schedule and conditions of each restricted stock unit. The price reported in Column 4 is an average execution price. These shares were sold in multiple transactions at prices ranging from $15.37 to $16.36, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. The price reported in Column 4 is an average execution price. These shares were sold in multiple transactions at prices ranging from $16.37 to $17.31, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. These securities are held directly by the KANG & CECILLIA SUN FAMILY REVOCABLE TRUST, for which the reporting person and his spouse are co-trustees.
Key Figures
Key Terms
Rule 10b5-1 trading plan regulatory
Stock Option (right to buy) financial
restricted stock units financial
open-market sale financial
family revocable trust financial
FAQ
What did Amprius (AMPX) director Sun Kang do in this Form 4 filing?
What stock options did Sun Kang exercise in Amprius (AMPX)?
What is the significance of the Rule 10b5-1 trading plan in this Amprius (AMPX) Form 4?
What restricted stock units does Sun Kang hold in Amprius (AMPX)?